Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
0.322
+0.001 (0.34%)
Sep 6, 2024, 4:00 PM EDT - Market closed
Cara Therapeutics Market Cap
Cara Therapeutics has a market cap or net worth of $17.67 million as of September 6, 2024. Its market cap has decreased by -89.15% in one year.
Market Cap
17.67M
Enterprise Value
8.21M
1-Year Change
-89.15%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since January 31, 2014, Cara Therapeutics's market cap has decreased from $282.00M to $17.67M, a decrease of -93.74%. That is a compound annual growth rate of -22.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 6, 2024 | 17.70M | -56.30% |
| Dec 29, 2023 | 40.50M | -92.98% |
| Dec 30, 2022 | 577.10M | -11.37% |
| Dec 31, 2021 | 651.10M | -13.65% |
| Dec 31, 2020 | 754.00M | 0.27% |
| Dec 31, 2019 | 752.00M | 46.65% |
| Dec 31, 2018 | 512.80M | 28.49% |
| Dec 29, 2017 | 399.10M | 57.44% |
| Dec 30, 2016 | 253.50M | -44.78% |
| Dec 31, 2015 | 459.10M | 102.16% |
| Dec 31, 2014 | 227.10M | -19.47% |
| Jan 31, 2014 | 282.00M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Minerva Neurosciences | 18.25M |
| Aprea Therapeutics | 18.20M |
| NEXGEL | 18.14M |
| Lyra Therapeutics | 17.85M |
| bioAffinity Technologies | 17.81M |
| NRx Pharmaceuticals | 17.41M |
| Matinas BioPharma Holdings | 17.31M |
| Cocrystal Pharma | 17.30M |